Skip to main content
. 2021 Sep 26;21:1007. doi: 10.1186/s12879-021-06706-3

Table 2.

Treatment outcomes for pre-ART cohorts in Central Kenya between 2004 and 2014

Cohort year P value
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
6-Month outcome  < 0.001
Not alive (n = 647) 19 (7.5) 29 (4.8) 18 (1.8) 75 (3.3) 125 (5.2) 143 (7.2) 109 (7.1) 68 (5.3) 15 (1.5) 23 (2.8) 23 (3.8)
LTFU (n = 6691) 143 (56.5) 359 (59.8) 536 (52.6) 1196 (52.8) 1190 (49.7) 902 (45.3) 681 (44.5) 563 (43.6) 441 (44.1) 353 (43) 327 (53.4)
Retention (n = 6441) 91 (36.0) 212 (35.3) 465 (45.6) 995 (43.9) 1081 (45.1) 947 (47.5) 741 (48.4) 659 (51.1) 544 (54.4) 444 (54.1) 262 (42.8)
12-Month outcome  < 0.001
Not alive (n = 764) 23 (9.1) 38 (6.3) 23 (2.3) 92 (4.1) 155 (6.5) 168 (8.4) 125 (8.2) 73 (5.7) 17 (1.7) 26 (3.2) 24 (3.9)
LTFU (n = 7857) 160 (63.2) 395 (65.8) 627 (61.5) 1360 (60.0) 1382 (57.7) 1088 (54.6) 826 (54.0) 691 (53.6) 520 (52.0) 429 (52.3) 379 (61.9)
Retention (n = 5158) 70 (27.7) 167 (27.8) 369 (36.2) 814 (35.9) 859 (35.9) 736 (36.9) 580 (37.9) 526 (40.8) 463 (46.3) 365 (44.5) 209 (34.2)